Health and nutrition claims for infant formula are poorly substantiated and potentially harmful
May 31, 2020
Despite improvements in infant formula over its 150 year history, it is still associated with health risks for mother and infant compared with breastfeeding. Manufacturers try to limit these risks through changes to formula composition, which are often accompanied by health or nutrition claims that aid product
differentiation or increase market value. Academics and regulators have raised concerns, however, that these claims are often unfounded and may undermine efforts to support breastfeeding. The current regulatory environment allows claims to be made for food products with low levels of evidence, but the potential harms associated with claims are higher for infant formula than for other foods. How can we prevent the
harms associated with infant formula claims while ensuring formula fed infants can benefit from improvements in formula composition?
SAMR issues guidance for evaluating scientific evidence for health claims
China
Jan 29, 2025
Health Canada will modify the “sugar-free” nutrient content claim
Canada
Jan 23, 2025
Canada - Government Sanctioned Health Claims, Regulations and Economic Policies: Strategies to Increase Consumption of Healthy Functional Foods in Canada
Canada
Dec 20, 2024
FDA announcing a final rule to update the definition of the nutrient content claim “healthy”
USA
Dec 20, 2024
Procedures for renewing healthy food certificates
China
Dec 19, 2024
FSANZ evaluates milk fat globule membrane as a nutritive substance
Australia
Dec 12, 2024
Court rules in favor of FTC in company's lawsuit over false health claims on dietary supplements
USA
Dec 11, 2024
Australia/EU - Health Claims and Their Regulation - Comparing Australia and Europe
Australia
Dec 06, 2024
New guidance for notifying permanent discontinuation of infant formula manufacturing
USA
Dec 04, 2024
CONAL will update the Food Code on health claims and incorporation of novel foods
Argentina
Dec 02, 2024
FSANZ revises specification for lacto-N-tetraose in infant formula products
Australia
Nov 26, 2024
ANVISA issues guidance on health claims
Brazil
Nov 25, 2024
FSANZ reviews new 2'-fucose-based lactose application for use in infant formulas
Australia
Nov 25, 2024
ANVISA publishes new interactive dashboard on authorized health claims
Brazil
Nov 20, 2024
Food Ministers meet to review regulatory developments on infant formula, infant formula, toddler milk and food labeling
Australia
Nov 18, 2024
Expertise in countries
- Argentina
- Australia
- Brazil
- Brunei
- Cambodia
- Canada
- Chile
- Colombia
- Ecuador
- Egypt
- European Union
- India
- Indonesia
- Laos
- Japan
- Malaysia
- Mexico
- Myanmar
- New Zealand
- Nigeria
- Paraguay
- Philippines
- Peru
- Russia
- Saudi Arabia
- Singapore
- South Africa
- South Korea
- Switzerland
- Thailand
- Turkey
- UAE
- UK
- Ukraine
- Uruguay
- USA
- Vietnam
